SCIENMAG: Medicine & Health

JULY 24, 2023

Centers for Disease Control and Prevention’s VISION Network, has determined both the number of adults needed to be vaccinated to prevent one COVID-19 associated hospitalization […] An analysis of real-world data from more than 1.2

Hospitals 84

Hospitals Vaccine Disease 84

Drug Discovery World

AUGUST 23, 2023

The US Food and Drug Administration (FDA) has approved the first vaccine for pregnant individuals to prevent respiratory syncytial virus (RSV) in infants. Edited by Diana Spencer, Senior Digital Content Editor, Drug Discovery World The post FDA approves RSV vaccine to protect babies from birth appeared first on Drug Discovery World (DDW).

FDA Approval 130

FDA Approval Vaccine FDA Virus 130

Drug Discovery World

MARCH 27, 2023

The first subjects have been dosed in a Phase I clinical trial of VXX-401, an investigational vaccine designed to lower low-density lipoprotein (LDL) cholesterol, a known factor in heart disease. With an LDL-lowering vaccine we can potentially offer an option that’s cost-effective, safe, convenient, long-acting, and deployable.”

Vaccine 130

Vaccine Immune Response Trials Clinical Trials 130

Drug Discovery World

OCTOBER 31, 2022

A new study in the US has revealed that the Covid-19 vaccine is less effective in people with weakened immune systems. . The research from the Centers for Disease Control and Prevention’s VISION Network analysed real-world data on mRNA vaccine effectiveness during Omicron BA.4 5 predominance for immunocompromised adults. .

Vaccine 130

Vaccine Virus Hospitals Treatment 130

Drug Discovery World

JULY 21, 2022

Two doses of Covid-19 vaccines were sufficient in providing protection against severe cases of the infectious disease, according to new research. . The researchers used NHS health records from over 7 million adults to assess vaccine effectiveness. Official comments. References . 1: [link] .

Vaccine 130

Vaccine Medical Schools Hospitals Science 130

Drugs.com

DECEMBER 15, 2023

15, 2023 -- Low vaccination rates for the flu, RSV and COVID-19 are putting Americans at higher risk for severe illness and hospitalization this winter, a new government alert warned Thursday.There is an “urgent need” to boost. FRIDAY, Dec.

Vaccine 115

Vaccine Government Hospitals 115

SCIENMAG: Medicine & Health

JANUARY 16, 2024

SA is often harmless, but it is also a leading cause of hospital-acquired and community-associated infections. A vaccine for SA would be a game-changer for public health, but for decades, all vaccine candidates for […]

Vaccine 72

Vaccine Hospitals 72

The Pharma Data

DECEMBER 17, 2020

Bernard Hospital today took delivery of the first batch of the Pfizer vaccine for the coronavirus, and Dr. Jennifer Atomah , director of the hospital’s pharmacy, placed the medicine in one of the ultra-cold freezers that allow that product to be stored for up to six months. Bernard Hospital. CHICAGO , Dec.

Hospitals 52

Hospitals Vaccine Pharmacy Production 52

The Pharma Data

MAY 16, 2022

The profound health and economic impact of the Pfizer-BioNTech vaccine during its first year of rollout in the US is described in detail in a new study in the peer-reviewed Journal of Medical Economics. It is estimated that in 2021 the vaccine, the most widely used against COVID-19 in the US, prevented 8.7

Vaccine 52

Vaccine Hospitals Virus Production 52

PLOS: DNA Science

DECEMBER 21, 2023

My third COVID article was perhaps the most cited, from February 20 of that first year, COVID-19-vaccine-will-close-in-on-the-spikes. I’d return to the topic of vaccines often, as for many people like myself they spelled a profound relief, while angering others, for reasons not apparently based on understanding the science.

DNA 91

DNA Vaccine Science Therapies 91

Drugs.com

JANUARY 12, 2024

12, 2024 -- Sickle cell disease is one of many chronic health conditions that dramatically increases the risk of hospitalization and death in people infected by COVID-19.Unfortunately, FRIDAY, Jan. Unfortunately, folks with sickle cell disease are much less.

Vaccine 137

Vaccine Hospitals Disease 137

Drugs.com

SEPTEMBER 11, 2023

11, 2023 – In a finding that should ease the minds of Americans ahead of another flu season, this year's vaccines have already cut the risk of hospitalization in half during the South American winter, health officials report. MONDAY, Sept.

Vaccine 64

Vaccine Hospitals 64

The Pharma Data

JANUARY 8, 2021

Laws Promoting Flu Shot for Hospital Workers Can Cut Deaths. 8, 2021 — State laws promoting hospital worker vaccination against influenza may be effective for reducing monthly pneumonia and influenza mortality rates, especially among the elderly, according to a study published online Jan. Professional. FRIDAY, Jan.

Hospitals 52

Hospitals Vaccine International Research 52

The Pharma Data

NOVEMBER 4, 2020

Not only cases are spiking: the number of people hospitalized with COVID-19 has reached record highs in a growing number of states. Missouri, Oklahoma, Iowa, Indiana, Nebraska, North Dakota and New Mexico all reported record high hospitalizations this week, the Associated Press reported. 15, the Washington Post reported.

Hospitals 52

Hospitals Vaccine Government Virus 52

The Pharma Data

DECEMBER 1, 2020

1, 2020 — Yet another grim record for COVID-19 hospitalizations was set on Monday, as more than 96,000 patients battled severe cases of the virus in hospital wards across America. But the number of hospitalizations have risen by more than 12 percent over the past week, the newspaper noted. TUESDAY, Dec. California Gov.

Hospitals 52

Hospitals Vaccine Virus Government 52

The Pharma Data

APRIL 20, 2022

Results of a new multicenter study published in the New England Journal of Medicine found that vaccination with a primary series of the Pfizer-BioNTech mRNA COVID-19 vaccine reduced the risk of COVID-19-associated hospitalizations in children ages 5-11 years by two-thirds during the Omicron period.

Vaccine 52

Vaccine Hospitals Research Disease 52

The Pharma Data

DECEMBER 4, 2021

In the first head-to-head comparison of the effectiveness of the Pfizer-BioNTech and Moderna COVID-19 vaccines, researchers examined the electronic health records of veterans who had received each vaccine. Both vaccines were highly effective in preventing COVID-19 outcomes such as documented infection, hospitalization, and death.

Vaccine 52

Vaccine Hospitals Medical Schools Research 52

The Pharma Data

DECEMBER 9, 2020

9, 2020 – In a sign that the coronavirus pandemic is entering its most dire stage yet, new federal data shows that more than a third of Americans now live in areas where hospitals are critically short of intensive care beds. The new hospital data shows that some areas — like Amarillo, Texas, Coral Gables, Fla., WEDNESDAY, Dec.

Hospitals 52

Hospitals Vaccine Government Doctors 52

Drug Discovery World

JULY 12, 2022

Urgent access to vaccines that can fight and prevent infections, and curb the risk of antimicrobial resistance (AMR) is needed to save lives, according to a report by the World Health Organisation (WHO). . More so, they currently have a very weak vaccine pipeline due to a low number of candidates and feasibility. type b) Tuberculosis?

Vaccine 130

Vaccine Hospitals Clinical Trials Disease 130

The Pharma Data

DECEMBER 12, 2020

Food and Drug Administration approved Pfizer’s coronavirus vaccine for emergency use on Friday, clearing the way for the launch of a national campaign to inoculate enough Americans to stem the spread of COVID-19. ” Who is first in line to be vaccinated? SATURDAY, Dec. 12, 2020 – The U.S.

FDA Approval 52

FDA Approval Vaccine FDA Nurses 52

The Pharma Data

DECEMBER 11, 2020

Food and Drug Administration is expected to approve emergency use of Pfizer’s coronavirus vaccine as early as Saturday after its advisory panel cleared the way for the start of a national campaign to inoculate Americans and stem the spread of COVID-19. Who is first in line? Centers for Disease Control and Prevention.

Vaccine 52

Vaccine FDA Hospitals Doctors 52

The Pharma Data

DECEMBER 3, 2020

Another record-breaking day of COVID-19 hospitalizations and deaths underscored Redfield’s grim warning. The number of people hospitalized for COVID-19 on Wednesday passed 100,000, nearly double the highest point seen last spring. With hospitals filling up in multiple states, the days ahead do appear bleak.

Hospitals 52

Hospitals Long-Term Care Facilities Vaccine Nurses 52

Drug Discovery World

AUGUST 1, 2023

Allogeneic cell vaccines In July 2023, Lineage Cell Therapeutics and Cancer Research UK announced encouraging primary and secondary endpoint results from their clinical study of VAC2 in advanced non-small cell lung cancer (NSCLC). “The

Vaccine 130

Vaccine Clinical Trials Drugs Hospitals 130

Eye on FDA

DECEMBER 10, 2020

Today the Food and Drug Administration will hold a meeting of the Vaccines and Related Biologics Advisory Committee (VRBAC) to consider the application for an Emergency Use Authorization (EUA) submitted by Pfizer/BioNTech for their investigative vaccine for COVID-19. After nearly 40 years, a vaccine still eludes us.

Vaccine 97

Vaccine FDA Virus Trials 97

The Pharma Data

DECEMBER 10, 2020

Food and Drug Administration advisory panel will vote on Thursday whether to recommend emergency approval of Pfizer’s coronavirus vaccine, a decision that will come not a moment too soon as the country reported more than 3,000 new COVID-19 deaths on Wednesday. Meanwhile, U.S.

Vaccine 52

Vaccine FDA Hospitals Doctors 52

The Pharma Data

JULY 8, 2021

People who receive mRNA COVID-19 vaccines are up to 91 percent less likely to develop the disease than those who are unvaccinated, according to a new nationwide study of eight sites, including Salt Lake City. Those who unfortunately got COVID-19 despite being vaccinated were still better off than those who didn’t.”

Vaccine 52

Vaccine Virus Nurses Hospitals 52

The Pharma Data

DECEMBER 14, 2020

14, 2020 (Healthday News) — The first shipments of nearly 3 million doses of the Pfizer coronavirus vaccine were on their way to hospitals in all 50 U.S. Because the vaccines can cause side effects including fevers and aches, hospitals have said they will stagger vaccinations among their workers. MONDAY, Dec.

Vaccine 52

Vaccine Nurses Assisted Living Hospitals 52

The Pharma Data

JANUARY 8, 2021

8, 2021 — The COVID-19 vaccine rollout is meeting resistance as many health care workers are refusing shots, the Associated Press reported Friday. It is occurring in nursing homes and to some degree in hospitals, with employees expressing fears of side effects. FRIDAY, Jan. Associated Press Article. © 2021 HealthDay.

Vaccine 52

Vaccine Nurses Hospitals Science 52

Drug Channels

JUNE 27, 2021

As you declare your vaccinated independence, celebrate with these Drug Channels fireworks: Amazon’s teeny step toward pharmacy disruption How patients view copay accumulators My $0.02 on generic and biosimilar trends Some hospitals seem to be gaming their 340B eligibility Plus, tips on effective hospital marketing.

Biosimilars 52

Biosimilars Hospitals Pharmacy Vaccine 52

The Pharma Data

MARCH 11, 2021

(NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced real-world evidence demonstrating dramatically lower incidence rates of COVID-19 disease in individuals fully vaccinated with the Pfizer-BioNTech COVID-19 Vaccine (BNT162b2), underscoring the observed substantial public health impact of Israel’s nationwide immunization program.

Vaccine 52

Vaccine Clinical Trials Hospitals Licensing 52

The Pharma Data

JANUARY 29, 2021

EU Regulator Approves Oxford-AstraZeneca COVID-19 Vaccine. 29, 2021 — European Union regulators have authorized the AstraZeneca COVID-19 vaccine for use in adults, CBS News reported Friday. The move comes after the European Medicines Agency has been criticized for not moving fast enough to vaccinate its population.

Regulations 52

Regulations Vaccine Hospitals Clinical Trials 52

The Pharma Data

DECEMBER 10, 2020

Food and Drug Administration advisory panel recommended on Thursday that the agency authorize the emergency use of Pfizer’s coronavirus vaccine, clearing the way for a national campaign to inoculate enough Americans to stop the spread of COVID-19. The FDA is expected to authorize the vaccine’s use within days, the Post reported.

Vaccine 52

Vaccine FDA Long-Term Care Facilities Hospitals 52

The Pharma Data

NOVEMBER 3, 2020

Influenza Vaccination May Have Protective Effect on COVID-19. 3, 2020 — Influenza vaccination may have a protective effect for COVID-19 -positive patients, according to a brief report recently published in the Journal of the American Board of Family Medicine. Influenza vaccination status and comorbidities were examined.

Vaccine 52

Vaccine Hospitals Disease Research 52

The Pharma Data

SEPTEMBER 25, 2020

A trial of a new vaccine that appears to train the immune system to fight coronavirus has begun in the UK. The trial on 10,000 people will now see if the vaccine can prevent people getting ill. A vaccine that can protect people from Covid-19 is still widely seen as the main exit strategy from the restrictions on all our lives.

Vaccine 52

Vaccine Trials Immune Response Virus 52

The Pharma Data

DECEMBER 4, 2021

The first peer-reviewed study in North America examining the timing between the first and second doses of COVID-19 mRNA vaccines shows that a longer dose interval leads to a stronger immune response. mRNA vaccines include the Pfizer-BioNTech Comirnaty vaccine and the Moderna Spikevax vaccine.

Immune Response 52

Immune Response Vaccine Hospitals Laboratories 52

The Pharma Data

AUGUST 17, 2020

More than 100,000 people have signed up to take part in future NHS trials of a coronavirus vaccine – but more volunteers are needed, researchers say. Kate Bingham, who chairs the UK’s vaccine taskforce, said: “These trials are safe, please sign up. Image copyright. Volunteers can register online. have blood tests.

Vaccine 52

Vaccine Clinical Trials Trials Virus 52

The Pharma Data

FEBRUARY 23, 2022

* Final analysis of the global VAT02 booster trial confirms universal ability to boost neutralizing antibodies 18- to 30-fold across vaccine platforms (mRNA, adenovirus). * efficacy against any symptomatic COVID-19 disease, in line with expected vaccine effectiveness in today’s environment dominated by variants of concern.

Vaccine 52

Vaccine Virus Trials Immune Response 52